2013
Antioxidant Status and APOE Genotype As Susceptibility Factors for Neurodegeneration in Alzheimer's Disease and Vascular Dementia
Zito G, Polimanti R, Panetta V, Ventriglia M, Salustri C, Siotto MC, Moffa F, Altamura C, Vernieri F, Lupoi D, Cassetta E, Rossini PM, Squitti R. Antioxidant Status and APOE Genotype As Susceptibility Factors for Neurodegeneration in Alzheimer's Disease and Vascular Dementia. Rejuvenation Research 2013, 16: 51-56. PMID: 23216585, PMCID: PMC3582293, DOI: 10.1089/rej.2012.1383.Peer-Reviewed Original ResearchConceptsAntioxidant statusΕ4 alleleVascular dementiaHealthy controlsSerum total antioxidant statusOxidative stressHigher WMH scoresTotal antioxidant statusWhite matter hyperintensitiesAPOE ε4 alleleElderly healthy controlsWMH scoresVaD patientsAtrophy assessmentLipid dyshomeostasisNeurodegenerative processesMatter hyperintensitiesPathogenetic pathwaysApolipoprotein EAlzheimer typeSystem homeostasisAlzheimer's diseaseTAS concentrationDisease riskLipid metabolism
1989
Reversible Anorexia and Rapid Weight Loss Associated With Neuroleptic Administration in Alzheimer's Disease
Rohrbaugh R, Siegal A. Reversible Anorexia and Rapid Weight Loss Associated With Neuroleptic Administration in Alzheimer's Disease. Journal Of Geriatric Psychiatry And Neurology 1989, 2: 45-47. PMID: 2568117, DOI: 10.1177/089198878900200109.Peer-Reviewed Original ResearchConceptsWeight lossAlzheimer's diseasePossible pathophysiological basisWeight Loss AssociatedAdequate dietary intakeReversible weight lossClinical courseNeuroleptic useNeuroleptic administrationPathophysiological basisAdvanced dementiaDietary intakeAlzheimer typeLoss AssociatedDiseasePatientsAnorexiaDementiaMalnutritionAdministrationIntake
1987
Olfactory Recognition: Differential Impairments in Early and Late Huntington's and Alzheimer's Diseases
Moberg P, Pearlson G, Speedie L, Lipsey J, Strauss M, Folstein S. Olfactory Recognition: Differential Impairments in Early and Late Huntington's and Alzheimer's Diseases. Journal Of Clinical And Experimental Neuropsychology 1987, 9: 650-664. PMID: 2961789, DOI: 10.1080/01688638708405208.Peer-Reviewed Original ResearchConceptsHuntington's diseaseOverall patient groupOlfactory brain regionsPatient groupAlzheimer groupSenile dementiaAlzheimer typeNormal controlsDisease processPatientsAlzheimer's diseaseBrain regionsCognitive deficitsHuntington's patientsGlobal impairmentDiseaseOlfactory discriminationOlfactory paradigmVisual performanceDifferential impairmentImpairmentDeficitsGroupOlfactory recognitionDementia
1986
Cerebral ventricular size and cerebrospinal fluid acetylcholinesterase levels in senile dementia of the Alzheimer type
Pearlson G, Tune L. Cerebral ventricular size and cerebrospinal fluid acetylcholinesterase levels in senile dementia of the Alzheimer type. Psychiatry Research 1986, 17: 23-29. PMID: 3484831, DOI: 10.1016/0165-1781(86)90038-7.Peer-Reviewed Original ResearchConceptsVentricle-brain ratioMini-Mental State ExaminationSenile dementiaComputed tomographyAlzheimer typeCerebrospinal fluid acetylcholinesterase activityLateral ventricle-brain ratiosCerebral ventricular sizeDuration of illnessAChE activityCSF AChE activityDegree of dementiaCerebral atrophyVentricular sizeCT scanDilutional effectState ExaminationCognitive impairmentAcetylcholinesterase levelsRadioenzymatic assayDementiaAcetylcholinesterase activityLaboratory dataPatientsSignificant correlation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply